SCHEMBL16391345

SCHEMBL16391345

CCC(=O)C1C2CCOC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16409190 0.77 — —
SCHEMBL255394 0.76 PPM1B (0.47) —
SCHEMBL29939170 0.74 — —
SCHEMBL8763778 0.74 — —
SCHEMBL8473651 0.74 — —
SCHEMBL29938649 0.72 — —
SCHEMBL29938575 0.72 — —
SCHEMBL29939189 0.72 — —
SCHEMBL3465102 0.72 — —
SCHEMBL16407775 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015005901-A1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-01-15 — — WO disclosed
Send feedback